Estrogen therapy replenishes vascular tetrahydrobiopterin and reduces oxidative stress in ovariectomized rats
Authors:
- Yen-Mei LeeYLYen-Mei Lee
- George HsiaoGHGeorge Hsiao
- Shu-Ying ChenSCShu-Ying Chen
- Mao-Hsiung YenMYMao-Hsiung Yen
- 1 March 2006
- journal article
- Published by Wolters Kluwer Health in Menopause
- Vol. 13 (2) , 294-302
Abstract
We investigated whether the effect of estrogen therapy on vascular endothelial function is mediated through increasing the bioavailability of tetrahydrobiopterin (BH4) and associated antioxidant capacity in ovariectomized (Ovx) rats. Aortas of sham-operated, Ovx, and Ovx plus estrogen therapy (Ovx + ET) female Sprague-Dawley rats were used to measure vascular reactivity. Plasma levels of nitric oxide (NO) metabolites, total antioxidant capacity, aortic superoxide anion (O2.), and BH4 contents were determined. Vascular reactivity, assessed on isolated aortic segments, indicated that phenylephrine-induced contraction in the Ovx group was significantly greater than that in the sham and Ovx + ET groups. The vasodilator responses to acetylcholine (10 to 10 M) and L-arginine (L-Arg; 10 M) in the sham and Ovx + ET groups were significantly greater than those in the Ovx group. Pretreatment with BH4 (10 M) enhanced the vasodilator responses to L-Arg in the Ovx group compared with the untreated Ovx group. An inhibitor of BH4 synthesis, 2,4-diamino-6-hydroxypyrimidine (2 mM), significantly attenuated the vasodilator response to L-Arg in the sham and Ovx + ET groups. In addition, Ovx significantly increased O2. production in aortic tissues and decreased plasma NO metabolites levels, whereas ET significantly prevented these effects. Pretreatment with BH4 also significantly decreased aortic O2. production in the Ovx group; both plasma total antioxidant capacity and aortic BH4 contents in the Ovx group decreased significantly compared with those in the sham group, which were also improved by ET. There were no significant differences in the protein expression of endothelial NO synthase in aortas in these groups. ET increases the availability of vascular BH4 to attenuate O2. production and restores total antioxidant capacity, leading to improved NO-mediated vasodilation in Ovx rats.Keywords
This publication has 31 references indexed in Scilit:
- Effects of oestrogen replacement on steady and pulsatile haemodynamics in ovariectomized ratsBritish Journal of Pharmacology, 2002
- Sex hormones and hypertensionCardiovascular Research, 2002
- Rapid actions of plasma membrane estrogen receptorsTrends in Endocrinology & Metabolism, 2001
- Estrogen Restores Endothelial Cell Function in an Experimental Model of Vascular InjuryCirculation, 1997
- Tetrahydrobiopterin and Dysfunction of Endothelial Nitric Oxide Synthase in Coronary ArteriesCirculation, 1995
- Cardiovascular Health and Disease in WomenNew England Journal of Medicine, 1993
- Short-term administration of estrogen and vascular responce of atherosclerotic coronary arteriesJACC, 1992
- Ca2+/calmodulin-dependent formation of hydrogen peroxide by brain nitric oxide synthaseBiochemical Journal, 1992
- Tetrahydrobiopterin, a cofactor for rat cerebellar nitric oxide synthase, does not function as a reactant in the oxygenation of arginine.Proceedings of the National Academy of Sciences, 1991
- Estrogen modulates responses of atherosclerotic coronary arteries.Circulation, 1990